C McCloud1, S Lake2. 1. Faculty of Medicine, Nursing and Health Science, Flinders University, Bedford Park, South Australia, Australia. 2. Flinders Medical Centre, Adelaide, South Australia, Australia.
Abstract
PURPOSE: In industrialised populations age-related macular degeneration (ARMD) is the leading cause of visual disability of the elderly. Successful new treatment with anti-endothelial growth factors for neovascular-classified ARMD has led to a divergence in treatment and experiences of people ARMD. This study aimed to understand the participant's experience of neovascular ARMD, including ongoing treatment with anti-vascular endothelial growth factor. METHODS: Twenty-five participants from one clinical site were qualitatively interviewed to elicit their experiences of treatment for neovascular ARMD. RESULTS: Two major themes were identified. A life negotiated by neovascular ARMD captures the participants' experience of living with the condition and treatment regime for neovascular ARMD. The second major theme: Uncertainty displayed their appraisal of life, treatment and their perceived future. CONCLUSIONS: Anxieties concerning the injections, new limitations to lifestyles, and an uncertain future all emerged from the data analysis. However, thankfulness for the treatment, the importance of familiar patterns in treatments and recovery and a guarded optimism also emerged. Knowledge of the experiences, anxieties and concerns of this patient population can be used to inform clinical practice and lead to patient-centred care.
PURPOSE: In industrialised populations age-related macular degeneration (ARMD) is the leading cause of visual disability of the elderly. Successful new treatment with anti-endothelial growth factors for neovascular-classified ARMD has led to a divergence in treatment and experiences of people ARMD. This study aimed to understand the participant's experience of neovascular ARMD, including ongoing treatment with anti-vascular endothelial growth factor. METHODS: Twenty-five participants from one clinical site were qualitatively interviewed to elicit their experiences of treatment for neovascular ARMD. RESULTS: Two major themes were identified. A life negotiated by neovascular ARMD captures the participants' experience of living with the condition and treatment regime for neovascular ARMD. The second major theme: Uncertainty displayed their appraisal of life, treatment and their perceived future. CONCLUSIONS:Anxieties concerning the injections, new limitations to lifestyles, and an uncertain future all emerged from the data analysis. However, thankfulness for the treatment, the importance of familiar patterns in treatments and recovery and a guarded optimism also emerged. Knowledge of the experiences, anxieties and concerns of this patient population can be used to inform clinical practice and lead to patient-centred care.
Authors: Hugh R Taylor; Jill E Keeffe; Hien T V Vu; Jie Jin Wang; Elena Rochtchina; M Lynne Pezzullo; Paul Mitchell Journal: Med J Aust Date: 2005-06-06 Impact factor: 7.738
Authors: Sandra C Tomany; Jie Jin Wang; Redmer Van Leeuwen; Ronald Klein; Paul Mitchell; Johannes R Vingerling; Barbara E K Klein; Wayne Smith; Paulus T V M De Jong Journal: Ophthalmology Date: 2004-07 Impact factor: 12.079
Authors: Samera Dean; Jonathan M Mathers; Melanie Calvert; Derek G Kyte; Dolores Conroy; Annie Folkard; Sue Southworth; Philip I Murray; Alastair K Denniston Journal: Br J Ophthalmol Date: 2017-04-28 Impact factor: 4.638
Authors: Rituparna Ghoshal; Sharanjeet Sharanjeet-Kaur; Norliza Mohamad Fadzil; Somnath Ghosh; Nor Fariza Ngah; Roslin Azni Abd Aziz Journal: Int J Environ Res Public Health Date: 2020-09-02 Impact factor: 3.390
Authors: Sobha Sivaprasad; Elizabeth A Tschosik; Robyn H Guymer; Audrey Kapre; Ivan J Suñer; Antonia M Joussen; Paolo Lanzetta; Daniela Ferrara Journal: Ophthalmol Ther Date: 2019-01-31